These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 9035988)

  • 1. [Medico-socio-economic aspects of mental health: impact of anxiety disorders].
    Martin P
    Rev Prat; 1999 Sep; 49(14 Suppl):S46-52. PubMed ID: 10887618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depressive disorders and public health: a review of the economic impact].
    Martin P
    Encephale; 1996; 22(5):321-30. PubMed ID: 9035988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medico-socioeconomic impact of anxiety disorders].
    Martin P
    Encephale; 1998; 24(3):280-96. PubMed ID: 9696924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic impact of bipolar mood disorders].
    Martin P
    Encephale; 1997 Jan; 23 Spec No 1():49-54. PubMed ID: 9172979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are psychological treatments for depression in primary care cost-effective?
    Bosmans JE; van Schaik DJ; de Bruijne MC; van Hout HP; van Marwijk HW; van Tulder MW; Stalman WA
    J Ment Health Policy Econ; 2008 Mar; 11(1):3-15. PubMed ID: 18424872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability from depression: the public health challenge to primary care.
    Rost K
    Nord J Psychiatry; 2009; 63(1):17-21. PubMed ID: 19023696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic and social burden of depression.
    Sartorius N
    J Clin Psychiatry; 2001; 62 Suppl 15():8-11. PubMed ID: 11444765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic considerations when evaluating treatment options for major depressive disorder.
    Burke MJ; Silkey B; Preskorn SH
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():42-52; discussion 53-4, 98-100. PubMed ID: 7961542
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.